Related Experiment Video
Updated: Jun 29, 2025
10:59
Visualizing the Conformational Dynamics of Membrane Receptors Using Single-Molecule FRET
Published on: August 17, 2022
3.2K
G Protein-Coupled Receptor Dimerization-What Next?
Marta Dziedzicka-Wasylewska1, Agnieszka Polit2, Ewa Błasiak2
1Department of Pharmacology, Maj Institute of Pharmacology, Polish Academy of Science, Smętna Street 12, 31-343 Kraków, Poland.
International Journal of Molecular Sciences
|March 28, 2024
Summary
Targeting G protein-coupled receptor (GPCR) heterodimers shows therapeutic promise, but clinical translation is hindered by complex in vivo environments. Lipid interactions with GPCRs offer new insights into cell signaling complexity.
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- G protein-coupled receptor (GPCR) heterodimers are crucial in various diseases.
- Despite basic research success, clinical translation of GPCR heterodimer drugs is limited.
- In vivo complexities, especially in the central nervous system, impede drug development.
Purpose of the Study:
- To review studied GPCR heterodimers and their role in nervous system pathology.
- To discuss potential ligands for GPCR heterodimers.
- To explore the role of lipids in GPCR dimerization and cell signaling.
Main Methods:
- Literature review of GPCR heterodimer research.
- Analysis of existing data on GPCR heterodimers and their ligands.
- Exploration of lipid-GPCR interactions in cell signaling.
Main Results:
- Identified key GPCR heterodimers involved in nervous system disorders.
- Summarized available ligand data for therapeutic targeting.
- Highlighted the significant, yet complex, role of lipids in GPCR dimerization and function.
Conclusions:
- GPCR heterodimers represent a promising therapeutic target, but challenges remain in clinical application.
- Understanding lipid modulation of GPCRs is essential for advancing drug development.
- Further research into GPCR-lipid interactions may unlock novel therapeutic strategies.
Related Concept Videos
01:15G Protein-coupled Receptors
11.9K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.9K
01:22Activation and Inactivation of G Proteins
7.1K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
7.1K
01:21G-protein Coupled Receptors
118.6K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
118.6K
01:30Transducer Mechanism: G Protein–Coupled Receptors
2.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
2.0K
01:30Assembly of Signaling Complexes
5.8K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.8K
01:11IP3/DAG Signaling Pathway
12.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K